id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2006-E-0197-0011,FDA,FDA-2006-E-0197,Letter from U.S. Patent and Trademark Office to Bristol-Myers Squibb Co.,Other,Letter(s),2008-10-29T04:00:00Z,2008,10,2008-10-29T04:00:00Z,,2025-12-19T00:55:02Z,,0,0,09000064807736b5
FDA-2006-E-0197-0010,FDA,FDA-2006-E-0197,Notice of Final Determination from U.S. Patent and Trademark Office to Bristol-Myers Squibb Company,Other,Letter(s),2008-10-29T04:00:00Z,2008,10,2008-10-29T04:00:00Z,,2025-12-19T00:50:34Z,,0,0,090000648068ce0e
FDA-2006-E-0197-0008,FDA,FDA-2006-E-0197,Application for Patent Term Extension from Bristol-Myers Squibb Company,Other,Application,2008-10-29T04:00:00Z,2008,10,2008-10-29T04:00:00Z,,2025-12-19T00:46:37Z,,0,0,0900006480450ef2
FDA-2006-E-0197-0009,FDA,FDA-2006-E-0197,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2008-10-29T04:00:00Z,2008,10,2008-10-29T04:00:00Z,,2025-12-19T00:48:12Z,,0,0,090000648068cdf4